Eisai
4523.T
$41.22
Share price
6.11%
Change (1 day)
-32.32%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
Eisai (4523.T) - Total debt
Total debt on the balance sheet as of March 2024 : A$1.70 Billion
According to Eisai's latest financial reports the company's total debt is A$1.70 Billion. A company’s total debt is the sum of all current and non-current debts.
Eisai - Total debt on balance sheet (from 2009 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-03-31 | A$1.61 B | 14.64% |
| 2023-03-31 | A$1.40 B | 35.99% |
| 2022-03-31 | A$1.03 B | -3.23% |
| 2021-03-31 | A$1.07 B | -20.63% |
| 2020-03-31 | A$1.34 B | -23.58% |
| 2019-03-31 | A$1.76 B | -16.7% |
| 2018-03-31 | A$2.11 B | -15.03% |
| 2017-03-31 | A$2.49 B | 5.49% |
| 2016-03-31 | A$2.36 B | -7.93% |
| 2015-03-31 | A$2.56 B | -1.01% |
| 2014-03-31 | A$2.59 B | -18.86% |
| 2013-03-31 | A$3.19 B | -20.33% |
| 2012-03-31 | A$4.01 B | -9.33% |
| 2011-03-31 | A$4.42 B | -7.5% |
| 2010-03-31 | A$4.78 B | -22.29% |
| 2009-03-31 | A$6.15 B | 35.81% |
| 2008-03-31 | A$4.53 B | 182730.31% |
| 2007-03-31 | A$2.48 M | -50.08% |
| 2006-03-31 | A$4.96 M | -50.67% |
| 2005-03-31 | A$10.07 M | 314.1% |
| 2004-03-31 | A$2.43 M | 394.79% |
| 2003-03-31 | A$0.49 M | -99.47% |
| 2002-03-31 | A$91.9 M | -28.95% |
| 2001-03-31 | A$0.12 B | -55.54% |
| 2000-03-31 | A$0.29 B |